Glancy Prongay & Murray LLP announces an investigation on behalf of investors of CytRx Corporation concerning the company and its officers’ possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of injured investors. CytRx is a biopharmaceutical research and development company that specializes in oncology. On July 11, 2016, CytRx released the…